SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.
Panama Grants 7 Medical Cannabis Licenses: Which Companies Got Them?
By Javier Hasse via El Planteo
SVB Leerink Downgrades AVEO Pharmaceuticals to Market Perform
SVB Leerink analyst Andrew Berens downgrades AVEO Pharmaceuticals (NASDAQ:AVEO) from Outperform to Market Perform.
Related Posts
XBiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke
XBiotech Inc. (NASDAQ:XBIT) Announces that Hutrukin is being developed by XBiotech as a breakthrough therapy to reduce brain injury after stroke. The last subject in a randomized, open-label, placebo-controlled
‘AI Revolution’ Key Narrative For Q4 Tech Earnings, Says Analyst, As He Flags A ‘Glaring Positive’ That Can Mitigate Bears’ Valuation Concerns
Tech companies are likely to have good fourth-quarter earnings tidings for the market, according to Wedbush Daniel Ives.
Autoworkers Union Talks Drive Ford And General Motors Stock Lower
Ford Motor Company (NYSE: F) and General Motors Company (NYSE: GM) shares are trading lower Thursday as shares of automakers fall